The Journal of Nutritional Biochemistry
Volume 22, Issue 4 , Pages 351-359 , April 2011

Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression

  • Yuan-Wen Lee

      Affiliations

    • Department of Anesthesiology, Taipei Medical University and Hospital, Taipei 110, Taiwan
    • ,
  • Jui-An Lin

      Affiliations

    • Department of Anesthesiology, Taipei Medical University and Hospital, Taipei 110, Taiwan
    • ,
  • Chuen-Chau Chang

      Affiliations

    • Department of Anesthesiology, Taipei Medical University and Hospital, Taipei 110, Taiwan
    • ,
  • Yung-Hsiang Chen

      Affiliations

    • Graduate Institute of Integrated Medicine, China Medical University, Taichung 404, Taiwan
    • ,
  • Po-Len Liu

      Affiliations

    • Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical, University, Kaohsiung 807, Taiwan
    • ,
  • Ai-Wei Lee

      Affiliations

    • Graduate Institute of Basic Medical Sciences and Department of Anatomy, Taipei Medical University, Taipei 110, Taiwan
    • ,
  • Jui-Chi Tsai

      Affiliations

    • Graduate Institute of Medical Sciences and Division of cardiovascular surgery, National Defense Medical Center, Taipei 114, Taiwan
    • Ta-Liang Chen and Jui-Chi Tsai contributed equal to the first author in this work.
    • ,
  • Chi-Yuan Li

      Affiliations

    • Graduate Institute of Clinical Medical Sciences and Department of Anesthesia, China Medical University and Hospital, Taichung 404, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Anesthesiology, School of Medicine, Taipei Medical University, Taipei, Taiwan.
    • ,
  • Chien-Sung Tsai

      Affiliations

    • Graduate Institute of Medical Sciences and Division of cardiovascular surgery, National Defense Medical Center, Taipei 114, Taiwan
    • ,
  • Ta-Liang Chen

      Affiliations

    • Department of Anesthesiology, Taipei Medical University and Hospital, Taipei 110, Taiwan
    • Ta-Liang Chen and Jui-Chi Tsai contributed equal to the first author in this work.
    • ,
  • Feng-Yen Lin

      Affiliations

    • Department of Anesthesiology, Taipei Medical University and Hospital, Taipei 110, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Anesthesiology, School of Medicine, Taipei Medical University, Taipei, Taiwan.

Received 21 September 2009 ,Revised 19 February 2010 ,Accepted 2 March 2010.

References 

  1. Muzio M, Mantovani A. Toll-like receptors. Microbes Infect. 2000;2:251–255
  2. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394–397
  3. Means TK, Golenbock DT, Fenton MJ. The biology of Toll-like receptors. Cytokine Growth Factor Rev. 2000;11:219–232
  4. O'Neill LA, Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol. 1998;63:650–657
  5. Carpenter S, O'Neill LA. How important are Toll-like receptors for antimicrobial responses?. Cell Microbiol. 2007;9:1891–1901
  6. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol. 2001;166:4620–4626
  7. Netea MG, Van der Graaf C, Van der Meer JW, Kullberg BJ. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis. 2004;23:672–676
  8. Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol. 2002;270:169–184
  9. Liu B, Dai J, Zheng H, Stoilova D, Sun S, Li Z. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A. 2003;100:15824–15829
  10. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279:7370–7377
  11. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002;195:99–111
  12. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 2003;278:1561–1568
  13. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol. 2004;172:20–24
  14. Li M, Zhou Y, Feng G, Su SB. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med. 2009;9:365–374
  15. Tsan MF, Clark RN, Goyert SM, White JE. Induction of TNF-alpha and MnSOD by endotoxin: role of membrane CD14 and Toll-like receptor-4. Am J Physiol Cell Physiol. 2001;280:C1422–C1430
  16. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–787
  17. Karlsson H, Larsson P, Wold AE, Rudin A. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect Immun. 2004;72:2671–2678
  18. Shiraki R, Inoue N, Kobayashi S, et al. Toll-like receptor 4 expressions on peripheral blood monocytes were enhanced in coronary artery disease even in patients with low C-reactive protein. Life Sci. 2006;80:59–66
  19. Satoh M, Shimoda Y, Maesawa C, et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol. 2006;109:226–234
  20. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett. 2003;85:85–95
  21. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet. 1992;340:1136–1139
  22. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AFA. placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAmA. 1997;278:1327–1332
  23. Varga E, Bodi A, Ferdinandy P, Droy-Lefaix MT, Blasig IE, Tosaki A. The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol. 1999;34:711–717
  24. Akiba S, Kawauchi T, Oka T, Hashizume T, Sato T. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int. 1998;46:1243–1248
  25. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun. 1994;201:748–755
  26. Yan LJ, Droy-Lefaix MT, Packer L. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Commun. 1995;212:360–366
  27. Shen JG, Zhou DY. Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury. Biochem Mol Biol Int. 1995;35:125–134
  28. Szabo ME, Droy-Lefaix MT, Doly M. Modification of reperfusion-induced ionic imbalance by free radical scavengers in spontaneously hypertensive rat retina. Free Radic Biol Med. 1992;13:609–620
  29. Lin FY, Chen YH, Lin YW, et al. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol. 2006;26:2622–2629
  30. Lin FY, Chen YH, Tasi JS, et al. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol. 2006;26:2630–2637
  31. Lin FY, Chen YH, Chen YL, et al. Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation. J Agric Food Chem. 2007;55:1977–1984
  32. Chen YH, Lin SJ, Lin FY, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes. 2007;56:1559–1568
  33. Zhang XY, Zhou DF, Cao LY, Wu GY. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2006;188:12–17
  34. Villasenor-Garcia MM, Lozoya X, Osuna-Torres L, Viveros-Paredes JM, Sandoval-Ramirez L, Puebla-Perez AM. Effect of Ginkgo biloba extract EGb 761 on the nonspecific and humoral immune responses in a hypothalamic-pituitary-adrenal axis activation model. Int Immunopharmacol. 2004;4:1217–1222
  35. Ho LJ, Lai JH. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr Drug Metab. 2004;5:181–192
  36. Sharma BK, Kumar K. Role of proinflammatory cytokines in cerebral ischemia: a review. Metab Brain Dis. 1998;13:1–8
  37. Watkins LR, Nguyen KT, Lee JE, Maier SF. Dynamic regulation of proinflammatory cytokines. Adv Exp Med Biol. 1999;461:153–178
  38. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117:1162–1172
  39. Jiao YB, Rui YC, Yang PY, Li TJ, Qiu Y. Effects of Ginkgo biloba extract on expressions of IL-1beta, TNF-alpha, and IL-10 in U937 foam cells. Yao Xue Xue Bao. 2007;42:930–934
  40. Jiao YB, Rui YC, Li TJ, Yang PY, Qiu Y. Expression of pro-inflammatory and anti-inflammatory cytokines in brain of atherosclerotic rats and effects of Ginkgo biloba extract. Acta Pharmacol Sin. 2005;26:835–839
  41. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem. 1993;268:12231–12234
  42. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363–380
  43. Juliet PA, Hayashi T, Iguchi A, Ignarro LJ. Concomitant production of nitric oxide and superoxide in human macrophages. Biochem Biophys Res Commun. 2003;310:367–370
  44. Brown GC. Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem. 1995;232:188–191
  45. Asahi M, Fujii J, Suzuki K, et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem. 1995;270:21035–21039
  46. Barker JE, Heales SJ, Cassidy A, Bolanos JP, Land JM, Clark JB. Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res. 1996;716:118–122
  47. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem. 1994;269:29405–29408
  48. Ilieva I, Ohgami K, Shiratori K, et al. The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res. 2004;79:181–187
  49. Wadsworth TL, Koop DR. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem Biol Interact. 2001;137:43–58
  50. Park YM, Won JH, Yun KJ, et al. Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-kappaB in RAW 264.7 cells. Biol Pharm Bull. 2006;29:985–990

PII: S0955-2863(10)00075-6

doi: 10.1016/j.jnutbio.2010.03.002

The Journal of Nutritional Biochemistry
Volume 22, Issue 4 , Pages 351-359 , April 2011

Article Tools

* Image Usage & Resolution